Notícias Longeveron Inc - LGVN | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Longeveron Inc (LGVN)
Longeveron Inc (LGVN) Notícias

Longeveron Inc (LGVN)

1,78

-0,04

(-2,20%)

Fechado 17 Dezembro 6:00PM

Atrasado por 15 minutos

1,79

0,01

( 0,56% )

Pré-mercado: 10:21AM

Atrasado por 15 minutos

Capacite seu portfólio: Discussões em tempo real e ideias de negociação acionáveis.

Longeveron to Attend Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Mesa

Longeveron® Announces Positive Type C Meeting with U.S. FDA Regarding Pathway to BLA for Lomecel-B™ in Hypoplastic Left Heart Syndrome (HLHS)

Longeveron to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Longeveron® Announces Second Quarter 2024 Financial Results and Provides Business Update

Longeveron® to Report Second Quarter 2024 Financial Results and Host Conference Call on August 14, 2024

Longeveron® Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference® (AAIC)

Longeveron Announces Closing of $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Longeveron Announces $9.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Longeveron® Announces U.S. FDA Grants Fast Track Designation for Lomecel-B™ for the Treatment of Mild Alzheimer’s Disease

Longeveron® Announces U.S. FDA Grants Lomecel-B™ Regenerative Medicine Advanced Therapy (RMAT) Designation for the Treatment of Mild Alzheimer’s Disease

Neha Motwani Elected to Longeveron® Board of Directors

Gene Therapy Pioneer Roger Hajjar, MD, Elected to Longeveron® Board of Directors

Life Science Virtual Investor Forum Presentations Now Available for Online Viewing

Longeveron Raises $4.4 Million in Gross Proceeds from Warrant Exercise Transaction

Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024

1
2
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições